Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027990
Filing Date
2024-12-02
Accepted
2024-12-02 16:22:56
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 form4-12022024_091252.html 4  
1 form4-12022024_091252.xml 4 3673
  Complete submission text file 0001415889-24-027990.txt   5232
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
ASADORIAN RAFFI (Reporting) CIK: 0001628970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 241519362